{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:29:16Z","timestamp":1789010956753,"version":"build-2803163510"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T00:00:00Z","timestamp":1715904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T00:00:00Z","timestamp":1715904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cancers of the kidney and renal pelvis are among the most prevalent types of urinary cancers. We aimed to outline the incidence trends of kidney and renal pelvis cancers by age, sex, race\/ethnicity, and histology in the United States (US) from 2000 to 2020. The data was obtained from the Surveillance, Epidemiology, and End Results (SEER) 22 database. The identification of patients with kidney and renal pelvis cancers with morphologies of renal cell carcinoma, nephroblastoma, sarcoma, and neuroendocrine tumor was conducted utilizing the International Classification of Diseases for Oncology version 3. The average annual percent change (AAPC) were presented. All estimates were given in the form of counts and delayed age-standardized incidence rates (ASIRs) per 100,000 people. From 2000 to 2019, a total of 490,481 cases of kidney and renal pelvic cancer were recorded across all age groups in the US. The majority of them were among Non-Hispanic Whites (NHWs) (69.75%) and those aged 55\u201369 years (39.96%). The ASIRs per 100,000 for kidney and pelvis cancers were 22.03 for men and 11.14 for women. Non-Hispanic Black men had the highest ASIR (24.53 [24.24, 24.81]), and increase in ASIR over the 2000\u20132019 period (AAPC: 2.19% [1.84, 2.84]). There was a noticeable increase in incidence of kidney and renal pelvis cancers. Individuals aged 70\u201384 years had the highest ASIR for kidney and renal pelvis cancers. The COVID-19 era has resulted in a significant reduction in incidence rates across all demographics.<\/jats:p>","DOI":"10.1038\/s41598-024-61748-2","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T11:03:23Z","timestamp":1715943803000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["A population-based study on incidence trends of kidney and renal pelvis cancers in the United States over 2000\u20132020"],"prefix":"10.1038","volume":"14","author":[{"given":"Seyed Ehsan","family":"Mousavi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morvarid","family":"Najafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Aslani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asra","family":"Fazlollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Yekta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Sadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Aria","family":"Nejadghaderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,17]]},"reference":[{"issue":"36","key":"61748_CR1","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1200\/JCO.2018.79.1905","volume":"36","author":"G Scelo","year":"2018","unstructured":"Scelo, G. & Larose, T. L. Epidemiology and risk factors for kidney cancer. J. Clin. Oncol. 36(36), 3574\u20133581 (2018).","journal-title":"J. Clin. Oncol."},{"key":"61748_CR2","unstructured":"Pandey, J. & Syed, W. Renal Cancer. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Wajihuddin Syed declares no relevant financial relationships with ineligible companies.: StatPearls Publishing Copyright \u00a9 2023, StatPearls Publishing LLC (2023)."},{"issue":"2","key":"61748_CR3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/bju.14533","volume":"123","author":"IM Michalek","year":"2019","unstructured":"Michalek, I. M. et al. Occupation and risk of cancer of the renal pelvis in Nordic countries. BJU Int. 123(2), 233\u2013238 (2019).","journal-title":"BJU Int."},{"issue":"3","key":"61748_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 71(3), 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"61748_CR5","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.eururo.2022.08.019","volume":"82","author":"L Bukavina","year":"2022","unstructured":"Bukavina, L. et al. Epidemiology of renal cell carcinoma: 2022 update. Eur. Urol. 82(5), 529\u2013542 (2022).","journal-title":"Eur. Urol."},{"issue":"4","key":"61748_CR6","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.euf.2017.01.006","volume":"4","author":"G Scelo","year":"2018","unstructured":"Scelo, G., Li, P., Chanudet, E. & Muller, D. C. Variability of sex disparities in cancer incidence over 30 years: The striking case of kidney cancer. Eur. Urol. Focus 4(4), 586\u2013590 (2018).","journal-title":"Eur. Urol. Focus"},{"issue":"4","key":"61748_CR7","doi-asserted-by":"publisher","first-page":"901","DOI":"10.4103\/jcrt.JCRT_217_16","volume":"17","author":"M Dursun","year":"2021","unstructured":"Dursun, M., Ozbek, E., Otunctemur, A. & Besiroglu, H. Differentiating renal pelvic cancer from renal cell carcinoma with 18-fluorodeoxyglucose positron emission tomography-computed tomography. J. Cancer Res. Ther. 17(4), 901\u2013905 (2021).","journal-title":"J. Cancer Res. Ther."},{"issue":"1","key":"61748_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. CA Cancer J. Clin. 73(1), 17\u201348 (2023).","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"61748_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.clgc.2018.10.002","volume":"17","author":"AM Saad","year":"2019","unstructured":"Saad, A. M. et al. Trends in renal-cell carcinoma incidence and mortality in the United States in the last 2 decades: A SEER-based study. Clin. Genitourin. Cancer 17(1), 46-57.e5 (2019).","journal-title":"Clin. Genitourin. Cancer"},{"key":"61748_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jss.2023.06.019","volume":"292","author":"T Haupt","year":"2023","unstructured":"Haupt, T. et al. Renal medullary carcinoma: A surveillance, epidemiology, and end results (SEER) analysis. J. Surg. Res. 292, 1\u20136 (2023).","journal-title":"J. Surg. Res."},{"issue":"1","key":"61748_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.eururo.2022.11.023","volume":"84","author":"EJ Schafer","year":"2023","unstructured":"Schafer, E. J. et al. Disparities and trends in genitourinary cancer incidence and mortality in the USA. Eur. Urol. 84(1), 117\u2013126 (2023).","journal-title":"Eur. Urol."},{"key":"61748_CR12","unstructured":"SEER. About the SEER Program\u2014SEER. Retrieved Jun 11, 2023, from https:\/\/seer.cancer.gov\/about\/overview.html."},{"key":"61748_CR13","unstructured":"The National Cancer Institute\u2019s SEER 22 databse. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence\u2014SEER Research Limited-Field Data with Delay-Adjustment, 22 Registries, Malignant Only, Nov 2022 Sub (2000\u20132020)\u2014Linked To County Attributes\u2014Time Dependent (1990\u20132021) Income\/Rurality, 1969\u20132021 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2023, based on the November 2022 submission."},{"key":"61748_CR14","unstructured":"Databse TNCIsS. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence\u2014SEER Research Limited-Field Data, 22 Registries, Nov 2022 Sub (2000\u20132020) - Linked To County Attributes\u2014Time Dependent (1990\u20132021) Income\/Rurality, 1969\u20132021 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2023, based on the November 2022 submission."},{"key":"61748_CR15","unstructured":"SEER. SEER Research Data Agreement. (n.d.). SEER. Retrieved Jun 11, 2023, from https:\/\/seer.cancer.gov\/data-software\/documentation\/seerstat\/nov2022\/seer-dua-nov2022.html."},{"key":"61748_CR16","unstructured":"The National Cancer Institute. Impact of COVID on 2020 SEER Cancer Incidence Data (2023)."},{"key":"61748_CR17","unstructured":"SEER. Surveillance Research Program, National Cancer Institute SEER*Stat software (seer.cancer.gov\/seerstat) version 8.4.1.2."},{"issue":"20","key":"61748_CR18","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1093\/jnci\/94.20.1537","volume":"94","author":"LX Clegg","year":"2002","unstructured":"Clegg, L. X., Feuer, E. J., Midthune, D. N., Fay, M. P. & Hankey, B. F. Impact of reporting delay and reporting error on cancer incidence rates and trends. J. Natl. Cancer Inst. 94(20), 1537\u20131545 (2002).","journal-title":"J. Natl. Cancer Inst."},{"key":"61748_CR19","unstructured":"Reporting Delay. In: Altekruse, S. F., Kosary, C. L., Krapcho, M., Neyman, N., Aminou, R., Waldron, W., Ruhl, J., Howlader, N., Tatalovich, Z., Cho, H., Mariotto, A., Eisner, M. P., Lewis, D. R., Cronin, K., Chen, H. S., Feuer, E. J., Stinchcomb, D. G., Edwards, B. K., editors. SEER Cancer Statistics Review, 1975\u20132007, National Cancer Institute. Bethesda, MD, based on November 2009 SEER data submission."},{"key":"61748_CR20","unstructured":"Institute TNC. Development of the Delay Model (2023)."},{"issue":"6","key":"61748_CR21","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1177\/0962280206070621","volume":"15","author":"RC Tiwari","year":"2006","unstructured":"Tiwari, R. C., Clegg, L. X. & Zou, Z. Efficient interval estimation for age-adjusted cancer rates. Stat. Methods Med. Res. 15(6), 547\u2013569 (2006).","journal-title":"Stat. Methods Med. Res."},{"key":"61748_CR22","unstructured":"The National Cancer Institute. Joinpoint Regression Program, Version 5.0.2\u2014May 2023; Statistical Methodology and Applications Branch, Surveillance Research Program, National Cancer Institute."},{"issue":"29","key":"61748_CR23","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1002\/sim.3733","volume":"28","author":"LX Clegg","year":"2009","unstructured":"Clegg, L. X., Hankey, B. F., Tiwari, R., Feuer, E. J. & Edwards, B. K. Estimating average annual per cent change in trend analysis. Stat. Med. 28(29), 3670\u20133682 (2009).","journal-title":"Stat. Med."},{"issue":"4","key":"61748_CR24","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1111\/j.0006-341X.2004.00256.x","volume":"60","author":"HJ Kim","year":"2004","unstructured":"Kim, H. J., Fay, M. P., Yu, B., Barrett, M. J. & Feuer, E. J. Comparability of segmented line regression models. Biometrics 60(4), 1005\u20131014 (2004).","journal-title":"Biometrics"},{"issue":"16","key":"61748_CR25","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1002\/sim.9407","volume":"41","author":"HJ Kim","year":"2022","unstructured":"Kim, H. J., Chen, H. S., Byrne, J., Wheeler, B. & Feuer, E. J. Twenty years since Joinpoint 1.0: Two major enhancements, their justification, and impact. Stat. Med. 41(16), 3102\u20133130 (2022).","journal-title":"Stat. Med."},{"key":"61748_CR26","unstructured":"The National Cancer Institute. Weighted BIC (WBIC)."},{"issue":"19","key":"61748_CR27","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1002\/sim.7344","volume":"36","author":"HJ Kim","year":"2017","unstructured":"Kim, H. J. et al. Improved confidence interval for average annual percent change in trend analysis. Stat. Med. 36(19), 3059\u20133074 (2017).","journal-title":"Stat. Med."},{"issue":"5","key":"61748_CR28","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nrurol.2010.46","volume":"7","author":"WH Chow","year":"2010","unstructured":"Chow, W. H., Dong, L. M. & Devesa, S. S. Epidemiology and risk factors for kidney cancer. Nat. Rev. Urol. 7(5), 245\u2013257 (2010).","journal-title":"Nat. Rev. Urol."},{"issue":"4","key":"61748_CR29","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jdiacomp.2013.01.004","volume":"27","author":"C Bao","year":"2013","unstructured":"Bao, C. et al. Diabetes mellitus and incidence and mortality of kidney cancer: A meta-analysis. J. Diabetes Complicat. 27(4), 357\u2013364 (2013).","journal-title":"J. Diabetes Complicat."},{"key":"61748_CR30","doi-asserted-by":"publisher","first-page":"1119374","DOI":"10.3389\/fpubh.2023.1119374","volume":"11","author":"YQ Tian","year":"2023","unstructured":"Tian, Y. Q. et al. Trends and risk factors of global incidence, mortality, and disability of genitourinary cancers from 1990 to 2019: Systematic analysis for the Global Burden of Disease Study 2019. Front. Public Health 11, 1119374 (2023).","journal-title":"Front. Public Health"},{"issue":"3","key":"61748_CR31","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.euf.2020.05.003","volume":"7","author":"C Palumbo","year":"2021","unstructured":"Palumbo, C. et al. Contemporary age-adjusted incidence and mortality rates of renal cell carcinoma: Analysis according to gender, race, stage, grade, and histology. Eur. Urol. Focus 7(3), 644\u2013652 (2021).","journal-title":"Eur. Urol. Focus"},{"issue":"16","key":"61748_CR32","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.3390\/cancers14164059","volume":"14","author":"T Makino","year":"2022","unstructured":"Makino, T., Kadomoto, S., Izumi, K. & Mizokami, A. Epidemiology and prevention of renal cell carcinoma. Cancers (Basel) 14(16), 4059 (2022).","journal-title":"Cancers (Basel)"},{"key":"61748_CR33","doi-asserted-by":"publisher","first-page":"101193","DOI":"10.1016\/j.pmedr.2020.101193","volume":"20","author":"GMA Kibria","year":"2020","unstructured":"Kibria, G. M. A. & Crispen, R. Prevalence and trends of chronic kidney disease and its risk factors among US adults: An analysis of NHANES 2003\u201318. Prev. Med. Rep. 20, 101193 (2020).","journal-title":"Prev. Med. Rep."},{"key":"61748_CR34","unstructured":"Wilms Tumor\u2014Childhood: Statistics [Available from: https:\/\/www.cancer.net\/cancer-types\/wilms-tumor-childhood\/statistics]."},{"issue":"9","key":"61748_CR35","doi-asserted-by":"publisher","first-page":"e28582","DOI":"10.1002\/pbc.28582","volume":"67","author":"JM Geris","year":"2020","unstructured":"Geris, J. M. & Spector, L. G. Race, ethnicity, and socioeconomic differences in incidence of pediatric embryonal tumors in the United States. Pediatric Blood Cancer 67(9), e28582 (2020).","journal-title":"Pediatric Blood Cancer"},{"issue":"6","key":"61748_CR36","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/ng.2251","volume":"44","author":"C Turnbull","year":"2012","unstructured":"Turnbull, C. et al. A genome-wide association study identifies susceptibility loci for Wilms tumor. Nat. Genet. 44(6), 681\u2013684 (2012).","journal-title":"Nat. Genet."},{"issue":"1","key":"61748_CR37","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jss.2011.03.011","volume":"170","author":"J Axt","year":"2011","unstructured":"Axt, J. et al. Race disparities in Wilms tumor incidence and biology. J. Surg. Res. 170(1), 112\u2013119 (2011).","journal-title":"J. Surg. Res."},{"issue":"9","key":"61748_CR38","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1136\/jmg.2006.041723","volume":"43","author":"RH Scott","year":"2006","unstructured":"Scott, R. H., Stiller, C. A., Walker, L. & Rahman, N. Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. J. Med. Genet. 43(9), 705\u2013715 (2006).","journal-title":"J. Med. Genet."},{"issue":"4","key":"61748_CR39","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1158\/1055-9965.EPI-16-0520","volume":"26","author":"AM Noone","year":"2017","unstructured":"Noone, A. M. et al. Cancer incidence and survival trends by subtype using data from the surveillance epidemiology and end results program, 1992\u20132013. Cancer Epidemiol. Biomarkers Prev. 26(4), 632\u2013641 (2017).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"4","key":"61748_CR40","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1016\/S0022-5347(05)00671-3","volume":"175","author":"A Cook","year":"2006","unstructured":"Cook, A. et al. Pediatric renal cell carcinoma: Single institution 25-year case series and initial experience with partial nephrectomy. J. Urol. 175(4), 1456\u20131460 (2006).","journal-title":"J. Urol."},{"issue":"4","key":"61748_CR41","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/S0022-5347(05)00696-8","volume":"175","author":"S Siemer","year":"2006","unstructured":"Siemer, S., Hack, M., Lehmann, J., Becker, F. & St\u00f6ckle, M. Outcome of renal tumors in young adults. J. Urol. 175(4), 1240\u20131243 (2006) (discussion 3-4).","journal-title":"J. Urol."},{"issue":"4","key":"61748_CR42","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.juro.2008.06.037","volume":"180","author":"RH Thompson","year":"2008","unstructured":"Thompson, R. H. et al. Renal cell carcinoma in young and old patients\u2014Is there a difference?. J. Urol. 180(4), 1262\u20131266 (2008) (discussion 6).","journal-title":"J. Urol."},{"issue":"3\u20134","key":"61748_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/19485565.2022.2149465","volume":"67","author":"ET Klopack","year":"2022","unstructured":"Klopack, E. T. et al. Socioeconomic status and immune aging in older US adults in the health and retirement study. Biodemography Soc. Biol. 67(3\u20134), 187\u2013202 (2022).","journal-title":"Biodemography Soc. Biol."},{"key":"61748_CR44","doi-asserted-by":"publisher","first-page":"895","DOI":"10.12944\/CRNFSJ.10.3.7","volume":"10","author":"A Senee","year":"2022","unstructured":"Senee, A., Yashwinee Bye, I. & Jeewon, R. An analysis of the contributors and factors influencing dietary patterns among the elderly population. Curr. Res. Nutr. Food Sci. J. 10, 895\u2013903 (2022).","journal-title":"Curr. Res. Nutr. Food Sci. J."},{"key":"61748_CR45","doi-asserted-by":"crossref","unstructured":"Terai, K., Glazer, A. & Miyazato N. Effects of the Elderly Population and of Political Factors in the US States 63\u201381 (2021).","DOI":"10.1007\/978-981-16-5536-4_5"},{"issue":"7","key":"61748_CR46","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1158\/1055-9965.EPI-20-0036","volume":"29","author":"M Dong","year":"2020","unstructured":"Dong, M. et al. Sex differences in cancer incidence and survival: A pan-cancer analysis. Cancer Epidemiol. Biomarkers Prev. 29(7), 1389\u20131397 (2020).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"18","key":"61748_CR47","doi-asserted-by":"publisher","first-page":"4588","DOI":"10.3390\/cancers13184588","volume":"13","author":"AJ Peired","year":"2021","unstructured":"Peired, A. J. et al. Sex and gender differences in kidney cancer: Clinical and experimental evidence. Cancers (Basel) 13(18), 4588 (2021).","journal-title":"Cancers (Basel)"},{"issue":"10","key":"61748_CR48","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein, S. L. & Flanagan, K. L. Sex differences in immune responses. Nat. Rev. Immunol. 16(10), 626\u2013638 (2016).","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"61748_CR49","doi-asserted-by":"publisher","first-page":"335","DOI":"10.4062\/biomolther.2018.103","volume":"26","author":"HI Kim","year":"2018","unstructured":"Kim, H. I., Lim, H. & Moon, A. Sex differences in cancer: Epidemiology, genetics and therapy. Biomol. Ther. (Seoul) 26(4), 335\u2013342 (2018).","journal-title":"Biomol. Ther. (Seoul)"},{"issue":"1","key":"61748_CR50","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3322\/caac.21440","volume":"68","author":"F Islami","year":"2018","unstructured":"Islami, F. et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J. Clin. 68(1), 31\u201354 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"61748_CR51","unstructured":"Centers for Disease Control and Prevention, Institute aNC. US Cancer Statistics Working Group. Rockville, MD, USA: Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute (2017)."},{"issue":"5","key":"61748_CR52","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.juro.2008.01.027","volume":"179","author":"HS Stafford","year":"2008","unstructured":"Stafford, H. S. et al. Racial\/ethnic and gender disparities in renal cell carcinoma incidence and survival. J. Urol. 179(5), 1704\u20131708 (2008).","journal-title":"J. Urol."},{"issue":"6","key":"61748_CR53","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.urology.2003.07.010","volume":"62","author":"UN Vaishampayan","year":"2003","unstructured":"Vaishampayan, U. N., Do, H., Hussain, M. & Schwartz, K. Racial disparity in incidence patterns and outcome of kidney cancer. Urology 62(6), 1012\u20131017 (2003).","journal-title":"Urology"},{"issue":"2","key":"61748_CR54","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/cncr.27690","volume":"119","author":"WH Chow","year":"2013","unstructured":"Chow, W. H., Shuch, B., Linehan, W. M. & Devesa, S. S. Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics. Cancer 119(2), 388\u2013394 (2013).","journal-title":"Cancer"},{"issue":"24","key":"61748_CR55","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1200\/JCO.2006.10.0156","volume":"25","author":"SI Berndt","year":"2007","unstructured":"Berndt, S. I., Carter, H. B., Schoenberg, M. P. & Newschaffer, C. J. Disparities in treatment and outcome for renal cell cancer among older black and white patients. J. Clin. Oncol. 25(24), 3589\u20133595 (2007).","journal-title":"J. Clin. Oncol."},{"issue":"16","key":"61748_CR56","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1002\/cncr.28126","volume":"119","author":"MS Eisenberg","year":"2013","unstructured":"Eisenberg, M. S., Leibovich, B. C. & Kim, S. P. Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics. Cancer 119(16), 3100 (2013).","journal-title":"Cancer"},{"issue":"7","key":"61748_CR57","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/j.1464-410X.2008.08119.x","volume":"103","author":"L Zini","year":"2009","unstructured":"Zini, L. et al. Race affects access to nephrectomy but not survival in renal cell carcinoma. BJU Int. 103(7), 889\u2013893 (2009).","journal-title":"BJU Int."},{"issue":"12","key":"61748_CR58","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1093\/jnci\/djz106","volume":"111","author":"EM Ward","year":"2019","unstructured":"Ward, E. M. et al. Annual report to the nation on the status of cancer, featuring cancer in men and women age 20\u201349 years. J. Natl. Cancer Inst. 111(12), 1279\u20131297 (2019).","journal-title":"J. Natl. Cancer Inst."},{"key":"61748_CR59","doi-asserted-by":"publisher","first-page":"101938","DOI":"10.1016\/j.canep.2021.101938","volume":"72","author":"PS Pinheiro","year":"2021","unstructured":"Pinheiro, P. S. et al. Kidney cancer mortality disparities among Hispanics in the US. Cancer Epidemiol. 72, 101938 (2021).","journal-title":"Cancer Epidemiol."},{"issue":"7_Supplement","key":"61748_CR60","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1158\/1538-7445.AM2023-722","volume":"83","author":"AA Murray","year":"2023","unstructured":"Murray, A. A. et al. Abstract 722: Epidemiological characterization of renal cell carcinoma in Hispanics: A single US center cohort study. Cancer Res. 83(7_Supplement), 722 (2023).","journal-title":"Cancer Res."},{"issue":"1_Supplement","key":"61748_CR61","doi-asserted-by":"publisher","first-page":"C121-C","DOI":"10.1158\/1538-7755.DISP22-C121","volume":"32","author":"AAM Melo","year":"2023","unstructured":"Melo, A. A. M., Gallegos, J. A. O. & Merchan, J. R. Abstract C121: Epidemiological characteristics and patterns of recurrence of renal cell carcinoma in Hispanics: A single US center cohort study. Cancer Epidemiol. Biomarkers Prev. 32(1_Supplement), C121-C (2023).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"10","key":"61748_CR62","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.3390\/jcm11102915","volume":"11","author":"M Bolufer","year":"2022","unstructured":"Bolufer, M. et al. Kidney biopsy in patients with cancer along the last decade: A multicenter study. J. Clin. Med. 11(10), 2915 (2022).","journal-title":"J. Clin. Med."},{"issue":"16","key":"61748_CR63","doi-asserted-by":"publisher","first-page":"e16554","DOI":"10.1200\/JCO.2023.41.16_suppl.e16554","volume":"41","author":"JAO Gallegos","year":"2023","unstructured":"Gallegos, J. A. O. et al. Clinical-pathological features and treatment outcomes in Hispanic\/Latino patients with advanced renal cell carcinoma at a single institution. J. Clin. Oncol. 41(16), e16554 (2023).","journal-title":"J. Clin. Oncol."},{"issue":"16_suppl","key":"61748_CR64","doi-asserted-by":"publisher","first-page":"e16555","DOI":"10.1200\/JCO.2023.41.16_suppl.e16555","volume":"41","author":"A Murray","year":"2023","unstructured":"Murray, A. et al. Epidemiologic and socioeconomic characteristics of Hispanics diagnosed with metastatic renal cell carcinoma in the US. J. Clin. Oncol. 41(16_suppl), e16555 (2023).","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"61748_CR65","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1200\/OP.20.00275","volume":"16","author":"DM Waterhouse","year":"2020","unstructured":"Waterhouse, D. M. et al. Early impact of COVID-19 on the conduct of oncology clinical trials and long-term opportunities for transformation: Findings from an american society of clinical oncology survey. JCO Oncol. Pract. 16(7), 417\u2013421 (2020).","journal-title":"JCO Oncol. Pract."},{"issue":"9","key":"61748_CR66","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1093\/jnci\/djad086","volume":"115","author":"AB Mariotto","year":"2023","unstructured":"Mariotto, A. B. et al. Interpreting cancer incidence trends: Challenges due to the COVID-19 pandemic. J. Natl. Cancer Inst. 115(9), 1109\u20131111 (2023).","journal-title":"J. Natl. Cancer Inst."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-61748-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-61748-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-61748-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T11:08:15Z","timestamp":1715944095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-61748-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,17]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["61748"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-61748-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,17]]},"assertion":[{"value":"1 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11294"}}